ADXN Wutah pendapatan kuartal marang kuartal addextherapeutics.com

The development of Addex Therapeutics (ADXN) depends on patents and the outcomes of drug trials for dystonia and Parkinson's disease. The quarterly revenue dynamics provided by GURU.Markets analytics demonstrate current trends, where the value -71.30 shows the current figure. Risk mitigation is ensured by the variety of research stages with global partners, while trial stability is guaranteed by optimized raw material procurement from diverse suppliers.
Rincian analitis lan laporan data perusahaan Addex Therapeutics, Ltd. (ADXN)

Addex Therapeutics specializes in developing safe allosteric modulators for the treatment of neurological diseases. This trend captures the percentage change in sales volume for the current quarter relative to the same period last year, allowing for an assessment of business resilience to market shocks by analyzing current quarterly revenue growth levels for long-term capital preservation.